Covid19 Clinical Trial
Official title:
Cardiac Structural and Functional Characteristics in COVID-19: A Dynamic Echocardiographic Study
The cardiovascular effects of coronavirus disease 2019 (COVID-19) are not yet fully known. We conducted a prospective and dynamic echocardiographic study to investigate the cardiac structural and functional changes in COVID-19 patients in intensive care unit (ICU).
The ongoing pandemic of coronavirus disease 2019 (COVID-19) caused by the newly discovered
severe acute respiratory syndrome coronavirus 2 (SAR-CoV-2) has become a global health
crisis, resulting in 3,435,894 confirmed infections and 239,604 deaths worldwide by 4 May
2020 1. Although acute respiratory syndrome is the main manifestation of the disease2, the
understanding of the impact of the virus on other organs is of importance in terms of
multiple organ dysfunction/failure that contributed to the increased mortality in patients
with COVID-19.
With the increase of confirmed cases and the accumulation of clinical data, the
cardiovascular manifestations caused by COVID-19 has raised concern3. Some studies have
reported that a certain percentage of patients presented cardiac injury as indicated by
elevated cardiac biomarkers such as high-sensitivity cardiac troponin-I (hs-cTnI) and brain
natriuretic peptide (BNP) 2,4,5. Cardiac complications, including acute heart failure,
cardiac rupture and even sudden cardiac arrest, has also been described in several case
reports 6-8. However, autopsy studies failed to find the evidence of direct assaults by the
virus in myocyte or apparent myocyte necrosis/apoptosis in the heart 9. Typical pathological
finding reported was mononuclear inflammatory infiltration in the myocardial interstitium but
no substantial damage in cardiomyocytes in the heart 10,11. Thus, a significant gap exists in
our knowledge between the clinical investigation and postmortem findings. At present, the in
vivo morphological and functional features of cardiac injury remain unknown.
We therefore performed a prospective and dynamic echocardiography study to investigate the
cardiac structural and functional changes in patients with COVID-19 who were admitted to
intensive care unit (ICU), and to compare the cardiac characteristics between deceased and
survived patients.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT05047692 -
Safety and Immunogenicity Study of AdCLD-CoV19-1: A COVID-19 Preventive Vaccine in Healthy Volunteers
|
Phase 1 | |
Recruiting |
NCT04395768 -
International ALLIANCE Study of Therapies to Prevent Progression of COVID-19
|
Phase 2 | |
Terminated |
NCT04555096 -
A Trial of GC4419 in Patients With Critical Illness Due to COVID-19
|
Phase 2 | |
Completed |
NCT04508777 -
COVID SAFE: COVID-19 Screening Assessment for Exposure
|
||
Completed |
NCT04506268 -
COVID-19 SAFE Enrollment
|
N/A | |
Completed |
NCT04961541 -
Evaluation of the Safety and Immunogenicity of Influenza and COVID-19 Combination Vaccine
|
Phase 1/Phase 2 | |
Active, not recruiting |
NCT04546737 -
Study of Morphological, Spectral and Metabolic Manifestations of Neurological Complications in Covid-19 Patients
|
N/A | |
Terminated |
NCT04581915 -
PHRU CoV01 A Trial of Triazavirin (TZV) for the Treatment of Mild-moderate COVID-19
|
Phase 2/Phase 3 | |
Completed |
NCT04532294 -
Safety, Tolerability, Pharmacokinetics, and Immunogenicity of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2/COVID-19) Neutralizing Antibody in Healthy Participants
|
Phase 1 | |
Completed |
NCT04494646 -
BARCONA: A Study of Effects of Bardoxolone Methyl in Participants With SARS-Corona Virus-2 (COVID-19)
|
Phase 2 | |
Not yet recruiting |
NCT04543006 -
Persistence of Neutralizing Antibodies 6 and 12 Months After a Covid-19
|
N/A | |
Terminated |
NCT04542993 -
Can SARS-CoV-2 Viral Load and COVID-19 Disease Severity be Reduced by Resveratrol-assisted Zinc Therapy
|
Phase 2 | |
Completed |
NCT04537663 -
Prevention Of Respiratory Tract Infection And Covid-19 Through BCG Vaccination In Vulnerable Older Adults
|
Phase 4 | |
Not yet recruiting |
NCT04527211 -
Effectiveness and Safety of Ivermectin for the Prevention of Covid-19 Infection in Colombian Health Personnel
|
Phase 3 | |
Completed |
NCT04507867 -
Effect of a NSS to Reduce Complications in Patients With Covid-19 and Comorbidities in Stage III
|
N/A | |
Completed |
NCT04387292 -
Ocular Sequelae of Patients Hospitalized for Respiratory Failure During the COVID-19 Epidemic
|
N/A | |
Not yet recruiting |
NCT05038449 -
Study to Evaluate the Efficacy and Safety of Colchicine Tablets in Patients With COVID-19
|
N/A | |
Completed |
NCT04979858 -
Reducing Spread of COVID-19 in a University Community Setting: Role of a Low-Cost Reusable Form-Fitting Fabric Mask
|
N/A | |
Completed |
NCT04610502 -
Efficacy and Safety of Two Hyperimmune Equine Anti Sars-CoV-2 Serum in COVID-19 Patients
|
Phase 2 | |
Active, not recruiting |
NCT06042855 -
ACTIV-6: COVID-19 Study of Repurposed Medications - Arm G (Metformin)
|
Phase 3 |